• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

国际原发性移植物功能障碍联合会:在心脏移植的当代时代重新定义临床风险因素。

The International Consortium on Primary Graft Dysfunction: Redefining Clinical Risk Factors in the Contemporary Era of Heart Transplantation.

机构信息

Ted Rogers Centre for Heart Research, University of Toronto, Toronto, Ontario, Canada.

UT Southwestern Medical Center, Dallas, Texas, USA.

出版信息

J Card Fail. 2024 Jun;30(6):805-815. doi: 10.1016/j.cardfail.2023.09.018. Epub 2023 Oct 30.

DOI:10.1016/j.cardfail.2023.09.018
PMID:37907150
Abstract

BACKGROUND

Primary graft dysfunction (PGD) is the leading cause of morbidity and mortality early after heart transplantation (HT). The International Consortium on PGD is a multicenter collaboration dedicated to identifying the clinical risk factors for PGD in the contemporary era of HT. The objectives of the current report were (1) to assess the incidence of severe PGD in an international cohort; (2) to evaluate the performance of the most strongly validated PGD risk tool, the RADIAL score, in a contemporary cohort; and (3) to redefine clinical risk factors for severe PGD in the current era of HT.

METHODS

This is a retrospective, observational study of consecutive adult HT recipients between 2010 and 2020 in 10 centers in the United States, Canada and Europe. Patients with severe PGD were compared to those without severe PGD (comprising those with no, mild and moderate PGD). The RADIAL score was calculated for each transplant recipient. The discriminatory power of the RADIAL score was evaluated using receiver operating characteristic (ROC) analysis, and its calibration was assessed by plotting the percentage of PGD predicted vs that which was observed. To identify clinical risk factors associated with severe PGD, we performed multivariable mixed-effects logistic regression modeling to account for among-center variability.

RESULTS

A total of 2746 patients have been enrolled in the registry to date, including 2015 (73.4%) from North America, and 731 (26.6%) from Europe; 215 participants (7.8%) met the criteria for severe PGD. There was an increase in the incidence of severe PGD over the study period (P value for trend by difference sign test = 0.004). The Kaplan-Meier estimate for 1-year survival was 75.7% (95% CI 69.4-80.9%) in patients with severe PGD as compared to 94.4% (95% CI 93.5-95.2%) in those without severe PGD (log-rank P value < 0.001). The RADIAL score performed poorly in our contemporary cohort and was not associated with severe PGD; it had an AUC of 0.53 (95% CI 0.48-0.58). In the multivariable regression model, acute preoperative dialysis (OR 2.41, 95% CI 1.31-4.43), durable left ventricular assist device support (OR 1.77, 95% CI 1.13-2.77), and total ischemic time (OR 1.20 for each additional hour, 95% CI 1.02-1.41) were associated with an increased risk of severe PGD.

CONCLUSIONS

Our consortium has identified an increasing incidence of PGD in the modern transplant era. We identified contemporary risk factors for this early post-transplant complication, which confers a high mortality risk. These results may enable the identification of patients at high risk for developing severe PGD in order to inform peri-transplant donor and recipient management practices.

摘要

背景

原发性移植物功能障碍(PGD)是心脏移植(HT)后早期发病率和死亡率的主要原因。PGD 国际联合会是一个多中心合作组织,致力于确定当代 HT 中 PGD 的临床危险因素。本报告的目的是:(1)评估国际队列中严重 PGD 的发生率;(2)评估最有力验证的 PGD 风险工具 RADIAL 评分在当代队列中的表现;(3)重新定义当代 HT 中严重 PGD 的临床危险因素。

方法

这是一项回顾性、观察性研究,纳入了 2010 年至 2020 年期间美国、加拿大和欧洲 10 个中心的连续成年 HT 受者。将发生严重 PGD 的患者与未发生严重 PGD 的患者(包括无、轻度和中度 PGD 患者)进行比较。为每个移植受者计算 RADIAL 评分。通过接受者操作特征(ROC)分析评估 RADIAL 评分的判别能力,并通过绘制预测 PGD 的百分比与观察到的百分比来评估其校准情况。为了确定与严重 PGD 相关的临床危险因素,我们进行了多变量混合效应逻辑回归建模,以解释中心间的变异性。

结果

迄今为止,该登记处共纳入了 2746 名患者,其中 2015 年(73.4%)来自北美,731 名(26.6%)来自欧洲;215 名患者(7.8%)符合严重 PGD 的标准。在研究期间,严重 PGD 的发生率呈上升趋势(差异符号检验的趋势检验 P 值=0.004)。与无严重 PGD 的患者相比,发生严重 PGD 的患者 1 年生存率的 Kaplan-Meier 估计值为 75.7%(95%CI 69.4-80.9%)(对数秩检验 P 值<0.001)。在我们的当代队列中,RADIAL 评分表现不佳,与严重 PGD 无关;其 AUC 为 0.53(95%CI 0.48-0.58)。在多变量回归模型中,术前急性透析(OR 2.41,95%CI 1.31-4.43)、持久左心室辅助装置支持(OR 1.77,95%CI 1.13-2.77)和总缺血时间(每增加 1 小时的 OR 为 1.20,95%CI 1.02-1.41)与严重 PGD 的风险增加相关。

结论

我们的联合会已经确定了在现代移植时代 PGD 发生率的增加。我们确定了这种早期移植后并发症的当代危险因素,这会带来高死亡率风险。这些结果可能能够识别出发生严重 PGD 风险较高的患者,以便为移植前供体和受者管理实践提供信息。

相似文献

1
The International Consortium on Primary Graft Dysfunction: Redefining Clinical Risk Factors in the Contemporary Era of Heart Transplantation.国际原发性移植物功能障碍联合会:在心脏移植的当代时代重新定义临床风险因素。
J Card Fail. 2024 Jun;30(6):805-815. doi: 10.1016/j.cardfail.2023.09.018. Epub 2023 Oct 30.
2
PREDICTA: A Model to Predict Primary Graft Dysfunction After Adult Heart Transplantation in the United Kingdom.PREDICTA:英国成人心脏移植后原发性移植物功能障碍预测模型。
J Card Fail. 2019 Dec;25(12):971-977. doi: 10.1016/j.cardfail.2019.07.009. Epub 2019 Jul 19.
3
Incidence, predictors, and outcomes after severe primary graft dysfunction in pediatric heart transplant recipients.儿童心脏移植受者严重原发性移植物功能障碍的发生率、预测因素和结局。
J Heart Lung Transplant. 2019 Jun;38(6):601-608. doi: 10.1016/j.healun.2019.01.1310. Epub 2019 Jan 24.
4
Risk Factors for Severe Primary Graft Dysfunction in Infants Following Heart Transplant.心脏移植术后婴儿发生严重原发性移植物功能障碍的危险因素。
J Am Heart Assoc. 2021 Jul 6;10(13):e021082. doi: 10.1161/JAHA.121.021082. Epub 2021 Jun 29.
5
Risk of severe primary graft dysfunction in patients bridged to heart transplantation with continuous-flow left ventricular assist devices.使用持续血流左心室辅助装置桥接心脏移植患者发生严重原发性移植物功能障碍的风险。
J Heart Lung Transplant. 2018 Dec;37(12):1433-1442. doi: 10.1016/j.healun.2018.07.013. Epub 2018 Jul 26.
6
Recipient and surgical factors trigger severe primary graft dysfunction after heart transplant.受者和手术因素可导致心脏移植后严重原发性移植物功能障碍。
J Heart Lung Transplant. 2021 Sep;40(9):970-980. doi: 10.1016/j.healun.2021.06.002. Epub 2021 Jun 10.
7
Application of the International Society for Heart and Lung Transplantation (ISHLT) criteria for primary graft dysfunction after cardiac transplantation: outcomes from a high-volume centre†.国际心肺移植学会(ISHLT)心脏移植后原发性移植物功能障碍标准的应用:来自一个高容量中心的结果†
Eur J Cardiothorac Surg. 2017 Feb 1;51(2):263-270. doi: 10.1093/ejcts/ezw271.
8
ISHLT Primary Graft Dysfunction Incidence, Risk Factors, and Outcome: A UK National Study.国际心肺移植学会原发性移植物功能障碍发生率、风险因素和结局:一项英国全国性研究。
Transplantation. 2019 Feb;103(2):336-343. doi: 10.1097/TP.0000000000002220.
9
Impact of controlled hypothermic preservation on outcomes following heart transplantation.心脏移植术后控制性低温保存对结局的影响。
J Heart Lung Transplant. 2024 Jul;43(7):1153-1161. doi: 10.1016/j.healun.2024.03.010. Epub 2024 Mar 19.
10
Improved Outcomes in Severe Primary Graft Dysfunction After Heart Transplantation Following Donation After Circulatory Death Compared With Donation After Brain Death.与脑死亡后捐献相比,心脏移植后循环死亡后捐献的严重原发性移植物功能障碍的预后改善。
J Card Fail. 2023 Jan;29(1):67-75. doi: 10.1016/j.cardfail.2022.10.429. Epub 2022 Nov 6.

引用本文的文献

1
Gene expression analysis of primary graft dysfunction in adult heart transplant recipients: A cohort study.成年心脏移植受者原发性移植功能障碍的基因表达分析:一项队列研究。
JHLT Open. 2025 Jan 22;9:100215. doi: 10.1016/j.jhlto.2025.100215. eCollection 2025 Aug.
2
Peripheral versus central cannulation of VA-ECMO for primary graft dysfunction after heart transplantation: A systematic review and meta-analysis.心脏移植后原发性移植物功能障碍患者行体外膜肺氧合(VA-ECMO)时外周置管与中心置管的比较:一项系统评价和荟萃分析
JHLT Open. 2024 Nov 8;7:100174. doi: 10.1016/j.jhlto.2024.100174. eCollection 2025 Feb.
3
National Organ Procurement and Transplant Network Heart Allocation Policy: 6 Years Later.
国家器官获取与移植网络心脏分配政策:6年后
Circ Heart Fail. 2025 Jun;18(6):e011631. doi: 10.1161/CIRCHEARTFAILURE.124.011631. Epub 2025 Mar 21.
4
Primary Graft Dysfunction after Heart Transplantation: Current Evidence and Implications for Clinical Practice.心脏移植后的原发性移植物功能障碍:当前证据及对临床实践的启示
Curr Cardiol Rep. 2025 Jan 15;27(1):24. doi: 10.1007/s11886-024-02153-z.
5
Mechanical Circulatory Support for Right Ventricular Primary Graft Dysfunction After Heart Transplant: A Review.心脏移植后右心室原发性移植物功能障碍的机械循环支持:综述
Clin Transplant. 2025 Jan;39(1):e70066. doi: 10.1111/ctr.70066.
6
CHIP-ing Away at Post-Transplant Outcomes: the Role of Somatic Mutations in Heart Transplant Outcomes.逐步改善移植后结局:体细胞突变在心脏移植结局中的作用
J Card Fail. 2025 Feb;31(2):411-414. doi: 10.1016/j.cardfail.2024.12.002. Epub 2024 Dec 20.
7
Risk prediction models of primary graft dysfunction in cardiac transplant patients: a need to improve?心脏移植患者原发性移植物功能障碍的风险预测模型:是否需要改进?
Front Cardiovasc Med. 2024 Sep 23;11:1478821. doi: 10.3389/fcvm.2024.1478821. eCollection 2024.
8
Primary graft dysfunction in heart transplantation: the challenge to survival.心脏移植中的原发性移植物功能障碍:对生存的挑战。
J Cardiothorac Surg. 2024 Jun 1;19(1):313. doi: 10.1186/s13019-024-02816-6.